Gal-3 overexpression in cancerous tissue has been associated with a poor prognosis in different cancer types including hepatocellular carcinoma [5], [6], clear cell renal carcinoma [7], [8] and bladder cancer [9]. This evidence concerns the gene LGALS3 and cancer.